Multigene tests for breast cancer: the physician’s perspective-Reference-Cited by-同舟云学术

Multigene tests for breast cancer: the physician’s perspective

Published:2021-04-27 Issue:9 Volume:12 Page:936-947
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Cognetti Francesco¹,Biganzoli Laura²,De Placido Sabino³,Mastro Lucia del⁴,Masetti Riccardo⁵,Naso Giuseppe⁶,Pruneri Giancarlo⁷,Santini Donatella⁸,Tondini Carlo Alberto⁹,Tinterri Corrado¹⁰,Tonini Giuseppe¹¹,Barni Sandro¹²

Affiliation:

1. Scuola di specializzazione di Oncologia, La Sapienza University, Rome, Italy

2. Sandro Pitigliani Medical Oncology Department, Hospital of Prato, Prato, Italy

3. Università Degli Studi di Napoli Federico II Dipartimento di Medicina clinica e Chirurgia Professore di Oncologia Medica, Napoli, Italy

4. Oncology, IRCCS AOU San Martino - IST Istituto Nazionale per la Ricerca del Cancro, Genova, Italy

5. Breast Center, Catholic University, Rome, Italy

6. Department of Radiology, Pathology and Oncology, La Sapienza University, Rome, Italy

7. Department of Pathology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy

8. Department of Pathology, IRCCS Azienda Ospedaliera Universitaria di Bologna, Policlinico di Sant’Orsola, Bologna, Italy

9. Medical Oncology, Papa Giovanni XXIII Hospital, Bergamo, Italy

10. Senology Unit, Humanitas Cancer Center, Rozzano, Milan, Italy

11. Medical Oncology, School University Campus Bio-Medico, Rome, Italy

12. Emeritus, Department of Oncology, ASST Bergamo Ovest, Treviglio, Bergamo, Italy

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Evolving Role of Genomic Testing in Early Breast Cancer: Implications for Diagnosis, Prognosis, and Therapy;International Journal of Molecular Sciences;2024-05-24

2. Prediction of a Multi-Gene Assay (Oncotype DX and Mammaprint) Recurrence Risk Group Using Machine Learning in Estrogen Receptor-Positive, HER2-Negative Breast Cancer—The BRAIN Study;Cancers;2024-02-13

3. Working tables on Hormone Receptor positive (HR+), Human Epidermal growth factor Receptor 2 negative (HER2-) early stage breast cancer: Defining high risk of recurrence;Critical Reviews in Oncology/Hematology;2023-11

4. Microfluidic Isolation of Disseminated Tumor Cells from the Bone Marrow of Breast Cancer Patients;International Journal of Molecular Sciences;2023-09-11

5. DCIS: Risk Assessment in the Molecular Era;Seminars in Radiation Oncology;2022-07